Mika Sakai-Okazawa
Matsuyama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis.
Journal: International journal of clinical oncology
Published: January 20, 2026
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.
Journal: Journal of gynecologic oncology
Published: October 10, 2025
Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study.
Journal: Japanese journal of clinical oncology
Published: July 25, 2025
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer.
Journal: Journal of gynecologic oncology
Published: June 14, 2024
Handling of Germline Findings in Clinical Comprehensive Cancer Genomic Profiling.
Journal: Acta medica Okayama
Published: December 22, 2022
Retroperitoneal leiomyosarcoma in a female patient with a germline splicing variant RAD51D c.904-2A > T: a case report.
Journal: Hereditary cancer in clinical practice
Published: August 09, 2021
Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma.
Journal: Journal of gynecologic oncology
Published: May 17, 2021
Uterine leiomyosarcoma well-controlled with eribulin mesylate.
Journal: International cancer conference journal
Published: August 01, 2018
Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
Journal: International journal of clinical oncology
Published: August 09, 2017
Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Journal: BMC cancer
Published: April 28, 2017
Last Updated: 09/26/2026